Is age-related macular degeneration a microvascular disease?

Advances in Experimental Medicine and Biology

Volumn 801, Issue , 2014, Pages 283-289

  Mullins, Robert F ^a   Khanna, Aditi ^a   Schoo, Desi P ^a   Tucker, Budd A ^a   Sohn, Elliott H ^a   Drack, Arlene V ^a   Stone, Edwin M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Age related macular degeneration; Choriocapillaris; Choroid; Complement; RPE

Indexed keywords

AGE RELATED MACULAR DEGENERATION; ARTICLE; CHOROID CAPILLARY LAYER; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; DISEASE MODEL; DRUSEN; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MICROANGIOPATHY; NONHUMAN; PATHOGENESIS; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; CAPILLARY; CHOROID; GENETICS; IMMUNOLOGY; PATHOLOGY; RETINA MACULA DEGENERATION; REVIEW;

COMPLEMENT;

CAPILLARIES; CHOROID; COMPLEMENT SYSTEM PROTEINS; GENOTYPE; HUMANS; MACULAR DEGENERATION;

EID: 84904821000     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3209-8_36     Document Type: Article

References (23)

1. Cahill MT, Banks AD, Stinnett SS, Toth CA (2005) Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology 112(1):152-158
2. Coleman AL, Yu F, Ensrud KE, Stone KL, Cauley JA, Pedula KL, Hochberg MC, Mangione CM (2010) Impact of age-related macular degeneration on vision-specific quality of life: Follow-up from the 10-year and 15-year visits of the Study of Osteoporotic Fractures. Am J Ophthalmol 150(5):683-691
3. Gorin MB. (2012) Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. Mol Aspects Med 33(4):467-486
4. Bhutto IA, Baba T, Merges C, Juriasinghani V, McLeod DS, Lutty GA (2011) C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration. Br J Ophthalmol 95(9):1323-1330
5. Holers VM (2008) The spectrum of complement alternative pathway-mediated diseases. Immunol Rev 223:300-316
6. Neher MD, Weckbach S, Flierl MA, Huber-Lang MS, Stahel PF (2011) Molecular mechanisms of inflammation and tissue injury after major trauma-is complement the "bad guy"? J Biomed Sci 18:90
7. Nozaki M, Raisler BJ, Sakurai E, Sarma JV, Barnum SR, Lambris JD, Chen Y, Zhang K, Ambati BK, Baffi JZ, Ambati J (2006) Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A 103(7):2328-2333
8. Skeie JM, Fingert JH, Russell SR, Stone EM, Mullins RF (2010) Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells. Invest Ophthalmol Vis Sci 51(10):5336-5342
9. Liu B, Wei L, Meyerle C, Tuo J, Sen HN, Li Z, Chakrabarty S, Agron E, Chan CC, Klein ML, Chew E, Ferris F, Nussenblatt RB (2011) Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med 9:1-12
10. Gerl VB, Bohl J, Pitz S, Stoffelns B, Pfeiffer N, Bhakdi S (2002) Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy. Invest Ophthalmol Vis Sci 43(4):1104-1108
11. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102(20):7227-7232
12. Seth A, Cui J, To E, Kwee M, Matsubara J (2008) Complement-associated deposits in the human retina. Invest Ophthalmol Vis Sci 49(2):743-750
13. Hecker LA, Edwards AO (2010) Genetic control of complement activation in humans and age related macular degeneration. Adv Exp Med Biol 703:49-62
14. Mullins RF, Dewald AD, Streb LM, Wang K, Kuehn MH, Stone EM (2011) Elevated membrane attack complex in human choroid with high risk complement factor H genotypes. Exp Eye Res 93(4):565-567
15. Pauleikhoff D, Spital G, Radermacher M, Brumm GA, Lommatzsch A, Bird AC (1999) A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. Arch Ophthalmol 117(10):1353-1358
16. Berenberg TL, Metelitsina TI, Madow B, Dai Y, Ying GS, Dupont JC, Grunwald L, Brucker AJ, Grunwald JE (2012) The association between drusen extent and foveolar choroidal blood flow in age-related macular degeneration. Retina 32(1):25-31
17. Yuan X, Gu X, Crabb JS, Yue X, Shadrach K, Hollyfield JG, Crabb JW (2010) Quantitative proteomics: comparison of the macular Bruch membrane/choroid complex from age-related macular degeneration and normal eyes. Mol Cell Proteomics 9(6):1031-1046
18. McLeod DS, Grebe R, Bhutto I, Merges C, Baba T, Lutty GA (2009) Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci 50(10):4982-4991
19. Mullins RF, Johnson MN, Faidley EA, Skeie JM, Huang J (2011) Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 52(3):1606-1612
20. Bhutto I, Lutty G (2012) Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Mol Aspects Med 33(4):295-317
21. Zhang L, Lee K, Niemeijer M, Mullins RF, Sonka M, Abramoff MD (2012) Automated segmentation of the choroid from clinical SD-OCT. Invest Ophthalmol Vis Sci 53(12):7510- 7519
22. Smailhodzic D, Klaver CC, Klevering BJ, Boon CJ, Groenewoud JM, Kirchhof B, Daha MR, den Hollander AI, Hoyng CB (2012) Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. Ophthalmology 119(2):339-346
23. Zeng S, Hernandez J, Mullins RF (2012) Effects of antioxidant components of AREDS vitamins and zinc ions on endothelial cell activation: implications for macular degeneration. Invest Ophthalmol Vis Sci 53(2):1041-1047